Works matching DE "BROMOCRIPTINE"

Results: 514

Bromocriptine for Idiopathic Intracranial Hypertension: A Retrospective Multicenter Cohort Study.

Published in:

International Journal of General Medicine, 2025, v. 18, p. 1933, doi. 10.2147/IJGM.S512250

By:

Morsy, Mahmoud M;
Azzam, Ahmed Y;
Mirdad, Mohammed Tarek;
Abadi, Alsaleem Mohammed;
Alqahtani, Saif Aboud M;
Abukhadijah, Hana J;
Elamin, Osman;
Morsy, Mohamed D;
Altschul, David J

Publication type:

Article

Neuroleptic malignant syndrome in cycloserine-induced psychosis.

Published in:

Indian Journal of Pharmacology, 2015, v. 47, n. 3, p. 328, doi. 10.4103/0253-7613.157134

By:

Sawant, Neena S.;
Kate, Natasha S.;
Bhatankar, Swaroop S.;
Kulk, Prathamesh S.

Publication type:

Article

Efficacy and safety of add on therapy of bromocriptine with metformin in Indian patients with type 2 diabetes mellitus: A randomized open labeled phase IV clinical trial.

Published in:

Indian Journal of Pharmacology, 2014, v. 46, n. 1, p. 24, doi. 10.4103/0253-7613.125160

By:

Ghosh, Arijit;
Sengupta, Nilanjan;
Sahana, Pranab;
Giri, Debasis;
Sengupta, Parama;
Das, Nina

Publication type:

Article

Olanzapine induced neuroleptic malignant syndrome.

Published in:

2013

By:

Patra, Bichitra Nanda;
Khandelwal, Sudhir K.;
Sood, Mamta

Publication type:

Case Study

Effect of bromocriptine on cardiovascular complications associated with metabolic syndrome in fructose fed rats.

Published in:

Indian Journal of Pharmacology, 2012, v. 44, n. 6, p. 688, doi. 10.4103/0253-7613.103248

By:

Nade, Vandana S.;
Kawale, Laxman A.;
Todmal, Umesh B.;
Tajanpure, Anjali B.

Publication type:

Article

Bromocriptine mesylate: FDA-approved novel treatment for type-2 diabetes.

Published in:

Indian Journal of Pharmacology, 2009, v. 41, n. 4, p. 197, doi. 10.4103/0253-7613.56070

By:

Mahajan, Rajiv

Publication type:

Article

Musical hallucinations induced by bromocriptine.

Published in:

Psychogeriatrics, 2004, v. 4, n. 3, p. 102, doi. 10.1111/j.1479-8301.2004.00056.x

By:

Kobayashi, Toshiyuki;
Miyata, Yoshifumi;
Okamoto, Shuhei;
Kato, Satoshi

Publication type:

Article

An observational study of pregnancy and post‐partum outcomes in women with prolactinoma treated with dopamine agonists.

Published in:

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2020, v. 60, n. 3, p. 405, doi. 10.1111/ajo.13070

By:

O'Sullivan, Susannah M.;
Farrant, Maritza T.;
Ogilvie, Cara M.;
Gunn, Alistair J.;
Milsom, Stella R.

Publication type:

Article

Pharmacological lactation suppression with D2 receptor agonists and risk of postpartum psychosis: A systematic review.

Published in:

Australian & New Zealand Journal of Obstetrics & Gynaecology, 2016, v. 56, n. 4, p. 336, doi. 10.1111/ajo.12479

By:

Snellen, Martien;
Power, Josephine;
Blankley, Gaynor;
Galbally, Megan

Publication type:

Article

Prospective analysis of serum prolactin levels, clinical symptomatology and sexual functions in patients with schizophrenia switched to paliperidone palmitate 3‐monthly from paliperidone palmitate 1‐monthly: Preliminary findings of the first 3 months

Published in:

Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 3, p. 1, doi. 10.1002/hup.2827

By:

Karslioğlu, Ersin Hatice;
Kolcu, Zeynep;
Karslioğlu, Nisa İrem;
Çayköylü, Ali

Publication type:

Article

Bromocriptine and quinpirole, but not 7-OH-DPAT or SKF 38393, potentiate the inhibitory effect of L-NAME on ethanol-induced locomotor activity in mice.

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2003, v. 367, n. 4, p. 414, doi. 10.1007/s00210-003-0700-0

By:

Uzbay, I. Tayfun;
Kayir, Hakan

Publication type:

Article

Is Na+ required for the binding of dopamine, amphetamine, tyramine, and octopamine to the human dopamine transporter?

Published in:

Naunyn-Schmiedeberg's Archives of Pharmacology, 2002, v. 365, n. 4, p. 303, doi. 10.1007/s00210-001-0526-6

By:

Li-Bin Li;
Xiao-Nan Cui;
Reith, Maarten E. A.

Publication type:

Article

Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans.

Published in:

Acta Diabetologica, 2014, v. 51, n. 1, p. 71, doi. 10.1007/s00592-013-0493-7

By:

Wagner, R.;
Heni, M.;
Linder, K.;
Ketterer, C.;
Peter, A.;
Böhm, A.;
Hatziagelaki, E.;
Stefan, N.;
Staiger, H.;
Häring, H.-U.;
Fritsche, A.

Publication type:

Article

Correlation of serum progestagen-associated endometrial protein levels with endometrial biopsies serum steroid levels and therapy for luteal phase defects.

Published in:

1991

By:

Check, Jerome H.;
Nowroozi, Kosrow;
Check, Matthew L.;
Vetter, Beth;
Check, J H;
Nowroozi, K;
Check, M L;
Vetter, B

Publication type:

journal article

Reduction in Acetylcholine Release in the Hippocampus of Dopamine D5 Receptor-Deficient Mice.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 9, p. 1620, doi. 10.1038/sj.npp.1300467

By:

Laplante, François;
Sibley, David R.;
Quirion, Rémi

Publication type:

Article

Synaptic Gating and ADHD: A Biological Theory of Comorbidity of ADHD and Anxiety.

Published in:

Neuropsychopharmacology, 2004, v. 29, n. 9, p. 1589, doi. 10.1038/sj.npp.1300469

By:

Levy, Florence

Publication type:

Article

Specific window of prolactin inhibition in late gestation decreases mammary parenchymal tissue development in gilts.

Published in:

Journal of Animal Science, 2003, v. 81, n. 7, p. 1823, doi. 10.2527/2003.8171823x

By:

Farmer, C.;
Petitclere, D.

Publication type:

Article

Inhibition of prolactin in the last trimester of gestation decreases mammary gland development in gilts.

Published in:

Journal of Animal Science, 2000, v. 78, n. 5, p. 1303, doi. 10.2527/2000.7851303x

By:

Farmer, C.;
Sorensen, M.T.

Publication type:

Article

Effects of photoperiod and slow-release preparations of bromocryptine and melatonin on reproductive activity and prolactin secretion in female goats2.

Published in:: Journal of Animal Science, 1994, v. 72, n. 4, p. 955, doi. 10.2527/1994.724955x
Publication type:: Article

Effects of bromocriptine treatment on the expression of sexual behavior in male sheep (Ovis aries)2.

Published in:: Journal of Animal Science, 1994, v. 72, n. 3, p. 591, doi. 10.2527/1994.723591x
Publication type:: Article

Dopaminergic D2-like receptor stimulation affects attention on contextual information and modulates BOLD activation of extinction-related brain areas.

Published in:

Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47704-6

By:

Nostadt, Alina;
Nitsche, Michael A.;
Tegenthoff, Martin;
Lissek, Silke

Publication type:

Article

Raynaud's phenomenon caused by cabergoline during the treatment of a macroprolactinoma: a case report.

Published in:

Revista Latinoamericana de Hipertension, 2021, v. 16, n. 2, p. 176, doi. 10.5281/zenodo.5514223

By:

González-Fernández, Laura;
Añez-Ramos, Roberto José;
Rivas-Montenegro, Alejandra Maricel;
Muñoz Moreno, Diego;
Percovich-Hualpa, Juan Carlos

Publication type:

Article

P31.12: Bromocriptine-treated giant lactating adenoma: a case report with imaging findings.

Published in:

Ultrasound in Obstetrics & Gynecology, 2014, v. 44, p. 367, doi. 10.1002/uog.14605

By:

Kang, Y.;
Kim, S.J.;
Min, J.

Publication type:

Article

Response to Caroff and Mann.

Published in:

Journal of Intensive Care Medicine, 1998, v. 13, n. 3, p. 151, doi. 10.1177/088506669801300308

By:

Fricchione, Gregory L.;
Fricchione

Publication type:

Article

Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro.

Published in:

1994

By:

Morikawa, K.;
Oseko, F.;
Morikawa, S.

Publication type:

Abstract

Effects of tolcapone and bromocriptine on cognitive stability and flexibility.

Published in:

Psychopharmacology, 2018, v. 235, n. 4, p. 1295, doi. 10.1007/s00213-018-4845-4

By:

Cameron, Ian G. M.;
Wallace, Deanna L.;
Al-Zughoul, Ahmad;
Kayser, Andrew S.;
D'Esposito, Mark

Publication type:

Article

Still trying to solve the catatonic dilemma - A comment on the Letter to the Editor by Loeb et al. (Psychopharmacology, 2015).

Published in:

2015

By:

Lang, Fabian;
Lang, Silke;
Becker, Thomas;
Jäger, Markus

Publication type:

Letter

DRD2 genotype predicts prefrontal activity during working memory after stimulation of D2 receptors with bromocriptine.

Published in:

Psychopharmacology, 2014, v. 231, n. 11, p. 2361, doi. 10.1007/s00213-013-3398-9

By:

Gelao, Barbara;
Fazio, Leonardo;
Selvaggi, Pierluigi;
Di Giorgio, Annabella;
Taurisano, Paolo;
Quarto, Tiziana;
Romano, Raffaella;
Porcelli, Annamaria;
Mancini, Marina;
Masellis, Rita;
Ursini, Gianluca;
De Simeis, Giuseppe;
Caforio, Grazia;
Ferranti, Laura;
Lo Bianco, Luciana;
Rampino, Antonio;
Todarello, Orlando;
Popolizio, Teresa;
Blasi, Giuseppe;
Bertolino, Alessandro

Publication type:

Article

Catatonia, Neuroleptic Malignant Syndrome, and Cotard Syndrome in a 22-Year-Old Woman: A Case Report.

Published in:

Case Reports in Psychiatry, 2013, p. 1, doi. 10.1155/2013/452646

By:

Weiss, C.;
Santander, J.;
Torres, R.

Publication type:

Article

Inhibition of SKP2 Sensitizes Bromocriptine-Induced Apoptosis in Human Prolactinoma Cells.

Published in:

Cancer Research & Treatment, 2017, v. 49, n. 2, p. 358, doi. 10.4143/crt.2016.017

By:

Jinxiang Huang;
Fenglin Zhang;
Lei Jiang;
Guohan Hu;
Wei Sun;
Chenran Zhang;
Xuehua Ding

Publication type:

Article

Effect of Bromocriptine Mesylate as Add-On Therapy in Obese Type 2 Diabetes Mellitus Patients.

Published in:

Iranian Journal of Diabetes & Obesity (IJDO), 2013, v. 5, n. 2, p. 88

By:

Dhore, Rajendra;
Dhore, Akshay;
Wasnik, Vinod;
Jadhav, Nilesh

Publication type:

Article

Nöreleptik Malign Sendrom: Bromokriptin İle Tedavi Edilen Bir Olgu.

Published in:

Dusunen Adam: Journal of Psychiatry & Neurological Sciences, 2010, v. 23, n. 3, p. 210, doi. 10.5350/dajpn2010230309

By:

Canbek, özge;
Sevim, Meltem Efe;
öncÜ, Fatih;
Soysal, HÜseyin

Publication type:

Article

Bromocriptine Treatment of Prolactin--Secreting Pituitary Adenomas May Restore Pituitary Function.

Published in:

Annals of Internal Medicine, 1984, v. 101, n. 6, p. 783, doi. 10.7326/0003-4819-101-6-783

By:

Warfield, Anna;
Finkel, David M.;
Schatz, Norman J.;
Savino, Peter J.;
Snyder, Peter J.

Publication type:

Article

Bromocriptine.

Published in:

Annals of Internal Medicine, 1984, v. 100, n. 1, p. 78, doi. 10.7326/0003-4819-100-1-78

By:

Vance, Mary Lee;
Evans, William S.;
Thorner, Michael O.

Publication type:

Article

Prolactinomas in women: current therapies.

Published in:

1983

By:

Robinson, Alan G.;
Robinson, A G;
Nelson, P B

Publication type:

journal article

Size reduction of extrasellar pituitary tumors during bromocriptine treatment.

Published in:

1982

By:

Wollesen, Flemming;
Andersen, Teis;
Karle, Agnete;
Wollesen, F;
Andersen, T;
Karle, A

Publication type:

journal article

Management of Acromegaly.

Published in:

1981

By:

Pearson, O.H.;
Arafah, B.;
Brodkey, J.

Publication type:

Editorial

LETTERS AND CORRECTIONS.

Published in:: Annals of Internal Medicine, 1979, v. 91, n. 5, p. 791
Publication type:: Article

LETTERS.

Published in:: 1979
Publication type:: Letter

Bromocriptine and Pituitary Disorders.

Published in:

1979

By:

Kellett, J.;
Friesen, H. G.

Publication type:

Editorial

Bromocriptine and Endocrine Disorders.

Published in:

Annals of Internal Medicine, 1979, v. 90, n. 6, p. 949, doi. 10.7326/0003-4819-90-6-949

By:

Spark, Richard F.;
Dickstein, Gabriel

Publication type:

Article

Galactorrhea-amenorrhea syndromes: etiology and treatment.

Published in:

1976

By:

Spark, Richard F.;
Pallotta, Johanna;
Naftolin, Frederic;
Clemens, Robin;
Spark, R F;
Pallotta, J;
Naftolin, F;
Clemens, R

Publication type:

journal article

Bromocriptine for the management of autonomic dysfunction after severe traumatic brain injury.

Published in:

2000

By:

Russo, Rn;
O’Flaherty, S;
Russo, R N;
O'Flaherty, S

Publication type:

journal article

Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines.

Published in:

Neurochemical Research, 2015, v. 40, n. 7, p. 1341, doi. 10.1007/s11064-015-1597-y

By:

Fischer, Andrew;
Matera, Kathryn

Publication type:

Article

Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells.

Published in:

Neurochemical Research, 2015, v. 40, n. 7, p. 1372, doi. 10.1007/s11064-015-1601-6

By:

Green, Ashley;
Hossain, Muhammad;
Tee, Siew;
Zarbl, Helmut;
Guo, Grace;
Richardson, Jason

Publication type:

Article

Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgia

Published in:

2004

By:

Kilicdag, E.B.;
Tarim, E.;
Bagis, T.;
Erkanli, S.;
Aslan, E.;
Ozsahin, K.;
Kuscu, E.

Publication type:

journal article

Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats.

Published in:

Synapse, 2003, v. 50, n. 2, p. 110, doi. 10.1002/syn.10248

By:

Masako Atsumi;
Junichi Kawakami;
Erika Sugiyama;
Hajime Kotaki;
Yasufumi Sawada;
Hitoshi Sato;
Yasuhiko Yamada;
Tatsuji Iga

Publication type:

Article

Erratum. Randomized Clinical Trial of Quick-Release Bromocriptine Among Patients With Type 2 Diabetes on Overall Safety and Cardiovascular Outcomes.

Published in:

2016

By:

Gaziano, J Michael;
Cincotta, Anthony H;
O'Connor, Christopher M;
Ezrokhi, Michael;
Rutty, Dean;
Ma, Z J;
Scranton, Richard E

Publication type:

journal article

Caveolin-1 sensitizes rat pituitary adenoma GH3 cells to bromocriptine induced apoptosis.

Published in:

Cancer Cell International, 2007, v. 7, p. 1, doi. 10.1186/1475-2867-7-1

By:

Yan-Nian Jiang;
Yi-Hung Li;
Meng-Wei Ke;
Ting-Yu Tseng;
Yueh-Bih Tang;
Mu-Chiou Huang;
Winston Teng-Kuei Cheng;
Yu-Ten Ju

Publication type:

Article

Bromocriptine for Type 2 Diabetes.

Published in:: OB/GYN Clinical Alert, 2011, p. 12
Publication type:: Article